There is a new MHRA Green Guide Update 2022 updated edition of the Rules and Guidance for Pharmaceutical Distributors called the MHRA Green Guide.
Compliance Monitoring Process – from April this year the MHRA are piloting a different approach to the monitoring of companies that are referred to the MHRA’s IAG (Inspection Action Group) for failure to comply with the standards of Good Manufacturing Practice or Good Distribution Practice.
Drug repurposing offers the possibility of a huge untapped source of safe and effective therapies for both common and rare conditions.
t National Patient Safety Team, and the British Association of Dermatologists, on the risk of inadvertent oral administration of potassium permanganate and the fear over safety when used.
The role of the auditor is not only to confirm compliance but is key to the improvement of processes across the company. Whether you work to GDP or ISO standards, it is a requirement that audits are carried out either internally or at the premises of your key suppliers to confirm compliance.
The pharmaceutical industry is a highly regulated sector where the paramount focus on minimising the risk to patient safety has led to significant changes in recent years.